Get Involved

Help make a difference in the lives of those with autoimmune disease.

What is Autoimmune Disease?
- AUTOIMMUNE VS AUTOINFLAMMATORY DISEASE
  
  A Comparative Look
  
  Autoimmune disease (AD) and autoinflammatory disease (AIF) are two categories of illnesses that occur when the immune system mistakenly damages healthy cells. Although these inflammatory disorders share many commonalities, there are key features that make them unique.
  Read Our Article
  Autoimmune diseases (AD) occur when the immune system attacks the body’s own healthy cells. There are 80-100 known autoimmune diseases and counting, affecting more than 14 million Americans.
  AUTOIMMUNE VS AUTOINFLAMMATORY DISEASE
  
  A Comparative Look
  
  Autoimmune disease (AD) and autoinflammatory disease (AIF) are two categories of illnesses that occur when the immune system mistakenly damages healthy cells. Although these inflammatory disorders share many commonalities, there are key features that make them unique.
  
  Read Our Article
Resources & Support
- FREE RESOURCE
  
  Find Hope in Your Health Journey
  
  The Autoimmune & Chronic Illness Toolkit includes journal templates, resource lists, guidance for doctor appointments, tips on communication, and many more tools to support and empower you throughout your experience.
  Get Our Guide
  Browse our resource lists and information via the links below.
  FREE RESOURCE
  
  Find Hope in Your Health Journey
  
  The Autoimmune & Chronic Illness Toolkit includes journal templates, resource lists, guidance for doctor appointments, tips on communication, and many more tools to support and empower you throughout your experience.
  
  Get Our Guide
Education & Research
- HIGHLIGHTED PARTNERSHIP
  
  An audio series hosted by the Celiac Program at Children’s National Hospital, in partnership with GAI
  
  Each episode has a featured hot topic in celiac disease including an interview with an expert, a nutritional discussion, and an update on news stories relating to the gluten-free community.
  View Gluten-Free Radio Podcast
  We support autoimmune disease education and research by funding grants for scientific investigations, holding live talks with experts, and partnering with the Celiac Disease Program to create educational resources.
  HIGHLIGHTED PARTNERSHIP
  
  An audio series hosted by the Celiac Program at Children’s National Hospital, in partnership with GAI
  
  Each episode has a featured hot topic in celiac disease including an interview with an expert, a nutritional discussion, and an update on news stories relating to the gluten-free community.
  
  View Gluten-Free Radio Podcast
About Us
- SPREADING AWARENESS
  
  We were proud to sponsor Nature Magazine’s July 2021 Outlook on Autoimmune Disease
  
  Learn more about GAI's work, autoimmune risk factors, research advances, and more!
  Read Our Feature
  The Global Autoimmune Institute is empowering solutions in the diagnosis and treatment of autoimmune disease (AD) through research, education, and community, while supporting multidisciplinary approaches to wellness.
  SPREADING AWARENESS
  
  We were proud to sponsor Nature Magazine’s July 2021 Outlook on Autoimmune Disease
  
  Learn more about GAI’s work, autoimmune risk factors, research advances, and more!
  
  Read Our Feature
Search

Autoimmune Diseases

6 Patients with Autoimmune Inflammatory Disorders Develop Shingles After mRNA Vaccine

April 21, 2021

The Tel Aviv Medical Center and Carmel Medical Center are conducting a study monitoring adverse events in patients with autoimmune inflammatory disorders. This includes patients with rheumatoid arthritis, vasculitis, myositis, Sjogren’s and spondyloarthritis for 6-weeks post COVID-19 vaccination. Of 491 patients with autoimmune inflammatory rheumatic diseases, six have been diagnosed with herpes zoster (shingles) for the first time after receiving an mRNA vaccine. Five cases occurred after receiving the first dose, and one after the second dose. Five of the six patients had not been vaccinated for shingles prior to receiving the COVID-19 vaccine.

NIH Funds Clinical Trial For New COVID-19 Antibody Therapy

April 19, 2021

The NIH is funding a Phase 2 clinical trial testing a monoclonal antibody for COVID-19 patients hospitalized with respiratory disease and low blood oxygen count. The FDA has previously issued emergency use authorization for COVID-19 antibody therapies by Eli Lilly and Regeneron.

Changing Vaccine Manufacturers Between Doses

April 2, 2021

The UK has established a vaccine protocol allowing patients to receive their first and second vaccine doses from different manufacturers. This is permissible if a second dose of the vaccine is unavailable or the manufacturer of the first dose is unknown. Currently, the only vaccines authorized for emergency use in the UK are by Pfizer, Moderna, and AstraZeneca.

Pfizer Confirms High Efficacy and Safety 6 Months Following Second Vaccine

April 1, 2021

Today, Pfizer released a statement confirming their vaccine has exhibited “high efficacy and no serious safety concerns through up to six months following the second dose.”

<< 1 … 23 24 25 26 27 28 >>

Chinese (Simplified)